Loading...

Laura A. Kalayjian, MD

TitleAssistant Professor of Clinical Neurology
InstitutionUniversity of Southern California
DepartmentNeurology
AddressHCC 3rd Floor Room 3000
Health Sciences Campus
Los Angeles CA 90089-9405
Phone+1 323 442 5710
vCardDownload vCard
    Other Positions
    TitleNeurology Chief, LAC+USC Medical Center

    TitleDirector, Neurophysiology Lab, LAC+USC Medical Center


    Collapse Biography 
    Collapse Awards and Honors
    Pasadena Magazine 2011Top Doctor

    Collapse Overview 
    Collapse Overview
    Dr. Laura Kalayjian is Chief of Neurology and Director of the EEG Lab at LAC+USC Medical Center. She completed medical school at the University of Massachusetts in Worcester, MA and completed her neurology residency at Stanford University, Palo Alto, CA. She was fellowship trained in epilepsy and neurophysiology under Dr. Martha Morrell at Columbia Presbyterian, New York. She accepted a position at USC in July 2000. She has been active as co-director of the comprehensive epilepsy program and continues to pursue her research interests in women with epilepsy, hormonal influences and pregnancy and quality of life issues in persons with epilepsy.


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Meador KJ, Pennell PB, May RC, Gerard E, Kalayjian L, Velez-Ruiz N, Penovich P, Cavitt J, French J, Hwang S, Pack AM, Sam M, Moore E, Ippolito DM. Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy. Epilepsy Behav. 2018 May 03; 84:10-14. PMID: 29730500.
      View in: PubMed
    2. Lee B, Zubair MN, Marquez YD, Lee DM, Kalayjian L, Heck CN, Liu CY. A Single-Center Experience with the NeuroPace RNS System: A Review of Techniques and Potential Problems. World Neurosurg. 2015 Sep; 84(3):719-26. PMID: 25940211.
      View in: PubMed
    3. Kalayjian L. Valproate and pregnancy: think again. Neurology. 2015 Jan 27; 84(4):e25-6. PMID: 25628438.
      View in: PubMed
    4. Fu KA, DiNorcia J, Sher L, Velani SA, Akhtar S, Kalayjian L, Sanossian N. Predictive factors of neurological complications and one-month mortality after liver transplantation. Front Neurol. 2014; 5:275. PMID: 25566180; PMCID: PMC4269112.
    5. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014 Aug; 168(8):729-36. PMID: 24934501; PMCID: PMC4122685.
    6. Cohen MJ, Meador KJ, Browning N, May R, Baker GA, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav. 2013 Nov; 29(2):308-15. PMID: 24012508; PMCID: PMC3902100.
    7. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013 Mar; 12(3):244-52. PMID: 23352199; PMCID: PMC3684942.
    8. Pennell PB, Klein AM, Browning N, Baker GA, Clayton-Smith J, Kalayjian L, Liporace JD, Privitera M, Crawford T, Loring DW, Meador KJ. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav. 2012 Aug; 24(4):449-56. PMID: 22749607; PMCID: PMC3483041.
    9. Herzog AG, Fowler KM, Smithson SD, Kalayjian L, Heck CN, Sperling MR, Liporace JD, Harden CL, Dworetzky BA, Pennell PB, Massaro JM. Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial. Neurology. 2012 Jun 12; 78(24):1959-66. PMID: 22649214; PMCID: PMC3369508.
    10. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology. 2012 Apr 17; 78(16):1207-14. PMID: 22491865; PMCID: PMC3324322.
    11. Cohen MJ, Meador KJ, Browning N, Baker GA, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav. 2011 Oct; 22(2):240-6. PMID: 21783425; PMCID: PMC3185140.
    12. Herzog AG, Fowler KM, Sperling MR, Liporace JD, Kalayjian L, Heck CN, Krauss GL, Dworetzky BA, Pennell PB. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia. 2011 Oct; 52(10):1843-8. PMID: 21756250; PMCID: PMC4572701.
    13. Herzog AG, Smithson SD, Fowler KM, Krishnamurthy KB, Sundstrom D, Kalayjian L, Heck CN, Oviedo S, Correl-Leyva G, Garcia E, Gleason KA, Dworetzky BA. Premenstrual dysphoric disorder in women with epilepsy: relationships to potential epileptic, antiepileptic drug, and reproductive endocrine factors. Epilepsy Behav. 2011 Aug; 21(4):391-6. PMID: 21724471.
      View in: PubMed
    14. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Cohen MJ, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav. 2011 Jun; 21(2):147-52. PMID: 21546316; PMCID: PMC3114203.
    15. Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011 Feb; 134(Pt 2):396-404. PMID: 21224309; PMCID: PMC3030767.
    16. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010 Nov 30; 75(22):1954-60. PMID: 21106960; PMCID: PMC3014232.
    17. Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, Pack A, Liporace JD, Sam M, Kalayjian L, Thurman DJ, Moore E, Loring DW. Antiepileptic drug use in women of childbearing age. Epilepsy Behav. 2009 Jul; 15(3):339-43. PMID: 19410654; PMCID: PMC2741411.
    18. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian L, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16; 360(16):1597-605. PMID: 19369666; PMCID: PMC2737185.
    19. Meador KJ, Baker GA, Finnell RH, Kalayjian L, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006 Aug 08; 67(3):407-12. PMID: 16894099; PMCID: PMC1986655.
    20. Morrell MJ, Flynn KL, Doñe S, Flaster E, Kalayjian L, Pack AM. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav. 2005 May; 6(3):360-5. PMID: 15820344.
      View in: PubMed
    Laura's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _